More than 90 percent of the medications that Americans take contain an inactive ingredient that could cause an allergic reaction, a new study suggests.
Sandoz announced the US market introduction of SYMJEPI (epinephrine) 0.3 mg Injection for the emergency treatment of allergic reactions (Type 1), including anaphylaxis.....